COVID-19 Briefing Series: European HCP Perspectives

Home / Intelligence / Briefs / COVID-19 Briefing Series: European HCP Perspectives

Highlights from Trinity’s Recent Research Focused on European HCP

The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide.

As the EU5 countries comprise some of the most important pharmaceutical markets, and with Italy, Spain and France includes countries which have been impacted significantly from COVID-19, Trinity aimed to understand the impact on HCP engagement with Market Research.

Publication access form

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.